Your browser doesn't support javascript.
loading
Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants.
Zhang, Wei; Bailey-Elkin, Ben A; Knaap, Robert C M; Khare, Baldeep; Dalebout, Tim J; Johnson, Garrett G; van Kasteren, Puck B; McLeish, Nigel J; Gu, Jun; He, Wenguang; Kikkert, Marjolein; Mark, Brian L; Sidhu, Sachdev S.
Afiliação
  • Zhang W; Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, and Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Bailey-Elkin BA; Department of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Knaap RCM; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Khare B; Department of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Dalebout TJ; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Johnson GG; Department of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
  • van Kasteren PB; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
  • McLeish NJ; Department of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Gu J; Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, and Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • He W; Department of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Kikkert M; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Mark BL; Department of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Sidhu SS; Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, and Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
PLoS Pathog ; 13(5): e1006372, 2017 May.
Article em En | MEDLINE | ID: mdl-28542609

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Proteínas Virais / Vírus da Febre Hemorrágica da Crimeia-Congo / Infecções por Coronavirus / Ubiquitina / Inibidores Enzimáticos / Coronavírus da Síndrome Respiratória do Oriente Médio / Febre Hemorrágica da Crimeia Tipo de estudo: Prognostic_studies Idioma: En Revista: PLoS Pathog Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Proteínas Virais / Vírus da Febre Hemorrágica da Crimeia-Congo / Infecções por Coronavirus / Ubiquitina / Inibidores Enzimáticos / Coronavírus da Síndrome Respiratória do Oriente Médio / Febre Hemorrágica da Crimeia Tipo de estudo: Prognostic_studies Idioma: En Revista: PLoS Pathog Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Canadá